<?xml version="1.0" encoding="UTF-8"?>
<p id="Par58">As we mentioned above, in interferon, monoclonal antibodies, and small molecules such as Janus kinases (JAKs) and signal transducer and activator of transcription proteins (STATs), JAKâ€“STAT signaling inhibitors appear to be effective as antiinflammatory agents capable to be used in the future to treat COVID-19. However, cost may be a concern. On the contrary, antigout drug colchicine and macrolides, such as azithromycin, could be a cheaper alternative.</p>
